BioNTech SE

Blood clots are more likely after Covid-19 than after vaccination

Modern hopes to have the booster shot ready for the fall, the CEO says

5 things to know before the stock market opens on Monday 12 April

The top manager admits low effectiveness

The South African Covid variant was able to “break” the Pfizer vaccine in an Israeli study

The United States begins study on assessment of allergic reactions to Pfizer and Moderna traits

Long-haul carriers report softening symptoms after receiving a shot

Fauci warns to relax public health measures as summer approaches

CDC relaxes Covid-19 travel guidelines for fully vaccinated people

Pfizer begins trial on infants and young children